These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 6230447

  • 21. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK, Altmann H, Tausch G, Eberl R.
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Distribution of gold in blood following administration of auranofin (SK&F D-39162).
    Walz DT, Griswold DE, DiMartino MJ, Bumbier EE.
    J Rheumatol Suppl; 1979; 5():56-60. PubMed ID: 114638
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
    Lorber A, Kunishima DH, Harralson AF, Simon TM.
    J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
    [Abstract] [Full Text] [Related]

  • 26. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E.
    Med Clin (Barc); 1985 May 25; 84(20):834-9. PubMed ID: 3928990
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Experiences to date with oral gold therapy].
    Zeidler H.
    Wien Klin Wochenschr Suppl; 1984 May 25; 156():22-7. PubMed ID: 6442052
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Auranofin in rheumatoid arthritis.
    Champion GD, Bieri D, Browne CD, Day RO, Graham GG, Haavisto TM, Sambrook PN, Vallance JB.
    J Rheumatol Suppl; 1982 May 25; 8():137-45. PubMed ID: 6813475
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate.
    Dahl SL, Coleman ML, Williams HJ, Altz-Smith M, Kay DR, Paulus HE, Weinstein A, Kaplan S.
    Arthritis Rheum; 1985 Nov 25; 28(11):1211-8. PubMed ID: 3933523
    [Abstract] [Full Text] [Related]

  • 37. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
    Bernhard GC.
    J Rheumatol Suppl; 1982 Nov 25; 8():149-53. PubMed ID: 6813477
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
    Ward JR, Williams HJ, Boyce E, Egger MJ, Reading JC, Samuelson CO.
    Am J Med; 1983 Dec 30; 75(6A):133-7. PubMed ID: 6419595
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.